These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32995769)

  • 1. The flexibility of ACE2 in the context of SARS-CoV-2 infection.
    Barros EP; Casalino L; Gaieb Z; Dommer AC; Wang Y; Fallon L; Raguette L; Belfon K; Simmerling C; Amaro RE
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flexibility of ACE2 in the context of SARS-CoV-2 infection.
    Barros EP; Casalino L; Gaieb Z; Dommer AC; Wang Y; Fallon L; Raguette L; Belfon K; Simmerling C; Amaro RE
    Biophys J; 2021 Mar; 120(6):1072-1084. PubMed ID: 33189680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain.
    Williams JK; Wang B; Sam A; Hoop CL; Case DA; Baum J
    Proteins; 2022 May; 90(5):1044-1053. PubMed ID: 34375467
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu Q; Wang Y; Leung EL; Yao X
    Comput Struct Biotechnol J; 2021; 19():5455-5465. PubMed ID: 34603638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.
    Sakkiah S; Guo W; Pan B; Ji Z; Yavas G; Azevedo M; Hawes J; Patterson TA; Hong H
    Front Chem; 2020; 8():622632. PubMed ID: 33469527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
    Dehury B; Raina V; Misra N; Suar M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
    Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.
    Nguyen K; Chakraborty S; Mansbach RA; Korber B; Gnanakaran S
    Viruses; 2021 May; 13(5):. PubMed ID: 34067878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F; Sami H
    J King Saud Univ Sci; 2022 Feb; 34(2):101773. PubMed ID: 34955621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites.
    Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
    Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
    Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
    Xu C; Wang Y; Liu C; Zhang C; Han W; Hong X; Wang Y; Hong Q; Wang S; Zhao Q; Wang Y; Yang Y; Chen K; Zheng W; Kong L; Wang F; Zuo Q; Huang Z; Cong Y
    Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33277323
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.